Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-18

Clinical Trial Update: Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure [NA]

View source ↗

Summary

A registered clinical trial is evaluating autologous adipose tissue-derived stromal cell therapy for ischemic heart failure. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous adipose tissue-derived stromal cell therapy

Snippet

Sponsor: Kanazawa University | Conditions: Ischemic Heart Failure | NA | Status: UNKNOWN